Medijski sadržaj
- Tweetovi
- Tweetovi i odgovori
- Medijski sadržaj, trenutna stranica.
-
Did you know that the reach of
#pharmaintelligence is unparalleled with over 350 experts supplying comprehensive news &#analysis. Find out how to boost your sales with#pharmaintelligence here http://bit.ly/3aXiURE pic.twitter.com/tY8o0gIjuV
-
From too much data to the stuggles of patient recruitment, these are a few of the issues that came to light in a recent study by
#Medidata. Learn more of the solution here http://bit.ly/38OLjI6 pic.twitter.com/wh0SCLV5NC
-
How are originator and
#generics industries diverging and to what extent to innovators want to play in the hybrid space? Download this article to find out http://bit.ly/2RwmLh6 pic.twitter.com/jqLkiCg0W0
-
A recent survey by
#NTTDATA has shed light on the potential for utlizing#machinelearning in precision-based#clinicaltrials. Register to learn more at our#webinar http://bit.ly/2NTRpyD pic.twitter.com/dO9PsTZJM2
-
Discover new opportunities for
#marketing success with partnering with the industry experts that#pharma leaders trust and rely on. Click to download your media kit here http://bit.ly/2tfMSj6 pic.twitter.com/vOGV5Mw3JL
-
Collaboration will help break down silos with one integrated solution as a single source of truth across all stakeholders. Learn more here http://bit.ly/2GGU7nn pic.twitter.com/0ALW4qcfX3
-
Get the latest news on the
#Coronavirus Outbreak from our experts at#Scrip and#MedtechInsight. Click here to access the latest analysis & intelligence: http://bit.ly/38XHBfc pic.twitter.com/JT9UnmGLt7
-
Resources are not keeping pace with increasingly complex
#clinicaltrials and#clinicalops/#clinops professionals are having difficulty completing their oversight responsibilities. Read the solution from a recent study by#Medidata here http://bit.ly/3aNMKIv pic.twitter.com/gC75LbElE5
-
[Article] Blurred Lines: Is the Generics Industry Moving into Big Pharma. Read more here http://bit.ly/3111krr pic.twitter.com/SPh6HbsnFW
-
Join us on February 27th at 10am ET as we explore the successes of applying
#machinelearning to various challenges in#clinicaltrials. Click here to register http://bit.ly/2RIqjvx pic.twitter.com/9OheEWJirW
-
#DIA is more than just a meeting, it is an experience that is focused on the future of#health and will feature more than 250 sessions over 13 unique tracks. Learn more here http://bit.ly/3asn8AB pic.twitter.com/At9lDIGAp5
-
65% of
#clinicaltrial professionals are asked to do more with less leading to an impact on oversight responsibilities http://bit.ly/2uEbZfE pic.twitter.com/rkRo6IGWwH
-
Follow the trends in robotic process automation (RPA) in
#pharma and#medtech with this free#whitepaper. Download here http://bit.ly/2Gg6bLQ pic.twitter.com/hOgBmh2m0C
-
With the number of confirmed deaths increasing every day, what impact will the Coronavirus have? http://bit.ly/36QD6Sk pic.twitter.com/DiqyN6EM6P
-
Learn how advances in automation are transforming process in
#lifesciences industries in our latest#whitepaper. Donwload here http://bit.ly/2up7xkG pic.twitter.com/x2IZu7Zfxd
-
Click to access our inspiring
#DIA2020 Overview Video and get a feel for the conference. http://bit.ly/2TKuU35 pic.twitter.com/KlEQ4qsBHl
-
Are you a
#gastroentrologist or work within the#NHS? Click to access our On Demand#webinar on a Inflammatory Bowel Disease Update. http://bit.ly/30Lse6E pic.twitter.com/MPNvjsxiYy
-
Understand the challenges of increasing
#clinicaltrial complexity and how they impact oversight responsibilities with this detailed#infographic here http://bit.ly/38HMxVp pic.twitter.com/XuDSSRxOqm
-
Will cutting through the noise of data help you make more rapid and informed decisions around clinical trials? Learn more about a 3-part solution for
#ClinicalTrial Oversight here http://bit.ly/37zUKuE pic.twitter.com/gKFeE2njRI
-
According to a recent survey by
#NTTDATA, patient awareness & access were the largest obstacles to enrollment in precision-based#clinicaltrials. Register for our#webinar to learn more http://bit.ly/2RhfS2X pic.twitter.com/fbjPqk518Y
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.